The reduced cell viability of RBN2397-treated cancer cell lines has been linked to senescence previously (24) and senescence markers CDKN1A (p21) and CKDN1B (p27) were also dramatically increased upon this treatment (Fig. 2E). Here, CDKN1A is linked to cancer.